The company we interviewed for this episode, Frequency Therapeutics, is the subject of the most active thread on the Tinnitus Talk forum, with nearly 1 million views. So of course, we wanted to hear from directly!
Frequency Therapeutics is working on a new hearing regeneration treatment. Preliminary results suggest the drug might work particularly well to improve speech intelligibility, something which traditional hearing aids have not been able to achieve.
We spoke with Carl LeBel, PhD, the company’s Chief Development Officer, about how the drug was discovered, whether it might benefit tinnitus, and why speech intelligibility should be the primary measure of hearing. We also touch on the burning question of when FX-322 might hit the market.
Visit our patient community at https://www.tinnitustalk.com
It’s the Data, Stupid! - Christopher Cederroth and David Stockdale
Tinnitus Realities - Steve and Sean
Tinnitus, Ingrained in the Brain? - Prof. Dirk De Ridder
The Sound of Science - Otonomy
Objectifying Tinnitus - The Bionics Institute
Visual Snow and Tinnitus - Phantom Phenomena
Tinnitus and the Power of Prediction - Dr. Will Sedley
Reviving Retigabine for Tinnitus - Thanos Tzounopoulos, PhD
Coronavirus Special: Tinnitus in Times of Quarantine
Healing Hearing, Silencing Tinnitus? - Hough Ear Institute
Transforming Hyperacusis Research - Bryan Pollard
Neuromod's Lenire - Treating Tinnitus the Bimodal Way
Clinical Guidelines for Tinnitus - Status Quo or Way Forward?
Hearing In, Tinnitus Out - Prof. Marcelo Rivolta
Tinnitus Management: Who Cares? - Richard Tyler, PhD
Tinnitus, The Musician's Curse? - CJ Wildheart
A World Without Tinnitus - David Stockdale (British Tinnitus Association)
In Search of a Tinnitus Cure - Dr. Josef Rauschecker
Passion Struck with John R. Miles
Harnessing Happiness with Sarah J Naylor
Awakening Divine Wildness
The Dr. Peter Breggin Hour
Copyright © 2006-2022 Podbean.com